Read more

June 08, 2023
13 min listen
Save

Healio Minute Podcast, Lung Cancer Edition: Top Headlines - Week of June 5, 2023

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this edition, surgery confers higher 5-year survival rates than radiotherapy; first-line combination extends PFS in lung cancer subgroup; pembrolizumab improves outcomes in early-stage resectable lung cancer, and more.

Read the full coverage here:

Surgery confers higher 5-year survival rates than radiotherapy in early-stage lung cancer

First-line combination extends PFS in lung cancer subgroup

Pembrolizumab improves outcomes in early-stage resectable lung cancer

Chemotherapy after first-line EGFR TKI fails to extend survival in advanced NSCLC

Severe myelosuppression common after chemotherapy for small cell lung cancer

References:

Hart L, et al. Cancer Med. 2023;doi:10.1002/cam4.5738.

Kanda S, et al. Abstract LBA9009. Presented at: ASCO Annual Meeting; June 2-6, 2023; Chicago.

Press Release

Udelsman B, et al. Abstract 275. Presented at: American Association for Thoracic Surgery Annual Meeting; May 6-9, 2023; Los Angeles.

Wakelee H, et al. Abstract LBA100. Presented at: ASCO Annual Meeting; June 2-6, 2023; Chicago.

Sources/Disclosures

Collapse

Disclosures: Please see each study for relevant financial disclosures.